Prof. Dr. Rainer Fietkau

Lehrstuhl für Strahlentherapie

ELDORANDO - Pembrolizumab compared with methotrexate in elderly, frail or cisplatin-ineligible patients with relapsed or metastatic squamous cell carcinoma of the head and neck (RM-SCCHN) (ELDORANDO-AIO-KHT-0115) (2021) Klinghammer K, Graeven U, Ivanyi P, Dietz A, Hahn D, Hackenberg S, Kasper S, et al. Conference contribution Hypofractionated Radiotherapy Upregulates Several Immune Checkpoint Molecules in Head and Neck Squamous Cell Carcinoma Cells Independently of the HPV Status While ICOS-L Is Upregulated Only on HPV-Positive Cells (2021) Wimmer S, Deloch L, Hader M, Derer A, Grottker F, Weissmann T, Hecht M, et al. Journal article Patterns of care analysis for salivary gland cancer: a survey within the German Society of Radiation Oncology (DEGRO) and recommendations for daily practice (2021) von der Grün J, Roedel C, Semrau S, Balermpas P, Martin D, Fietkau R, Haderlein M Journal article TNT in rectal cancer: Final results of the CAO/ARO/AIO-12 randomized phase 2 trial (2021) Fokas E, Schlenska-Lange A, Polat B, Klautke G, Fietkau R, Kuhnt T, Brunner T, et al. Conference contribution Cell-in-cell phenomenon: leukocyte engulfment by non-tumorigenic cells and cancer cell lines (2021) Bauer M, Hader M, Hecht M, Büttner-Herold M, Fietkau R, Distel L Journal article Therapies for synchronous malignomas - the importance of interdisciplinary oncology (2021) Müller SK, Haderlein M, Traxdorf M, Semrau S, Agaimy A, Lettmaier S, Gostian AO, et al. Journal article, Editorial 12 x 6 Gy stereotactic radiotherapy for lung tumors. Is there a difference in response between lung metastases and primary bronchial carcinoma? (2021) Lubgan D, Semrau S, Lambrecht U, Gaipl U, Fietkau R Journal article Longitudinal C-reactive protein (CRP) as an individualized dynamic predictor for metastatic cancer patients treated with immune checkpoint inhibitors: Findings from the prospective ST-ICI cohort. (2021) Zhou JG, Ma H, Gaipl U, Frey B, Hecht M, Fietkau R Conference contribution A Prospective Real-World Multi-Center Study to Evaluate Progression-Free and Overall Survival of Radiotherapy with Cetuximab and Platinum-Based Chemotherapy with Cetuximab in Locally Recurrent Head and Neck Cancer (2021) Hecht M, Hahn D, Wolber P, Hautmann MG, Reichert D, Weniger S, Belka C, et al. Journal article The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents (2021) Dürr P, Schlichtig K, Kelz C, Deutsch B, Maas R, Eckart MJ, Wilke J, et al. Journal article